Specwarop.....................AVR would not even be on the radar of big institutions at this time..
- 1 would not fit their overall conditions to buy it-
-2 Market cap too small. Not in any ASX 'index' at this time.
-3 Liquidity very tiny as is the shares on issue. This is a big point from any Fund Managers view.
-4 No income
-5 Product not yet a proven or market accepted fact
Just to mention a few matters there are others. How if any one of the above is a 'no' then the rest would possibly not be considered.
I would also suggest some small Fund Managers -may have it under 'watch' but 'no touch' at this point.
Speculators at this time - yes. Short term traders -again liquidity is a challenge. Any negative news this would drop like a hot potato. I am not expecting any but there are such things as 'Black Swan' events
My view - product at this stage from what has been tested- 'looks great'. Also some of the stats are impressive as to the time frames the product(s) have been tested. Worth a 'buy' yes but only for ME from my research and my view. Everyone must do their own research.
Following my comments could be a disaster. True I am searching for my next $5 million..... I have given up any hope on the last $ 5 mill.
Keep safe all
The Phantom GWW
- Forums
- ASX - By Stock
- AVR
- Wayne presenting at the ASX small and mid cap conference 16th March
Wayne presenting at the ASX small and mid cap conference 16th March, page-20
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$9.91 |
Change
-0.090(0.90%) |
Mkt cap ! $209.4M |
Open | High | Low | Value | Volume |
$10.00 | $10.00 | $9.65 | $70.76K | 7.202K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 300 | $9.80 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$9.91 | 475 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 300 | 9.800 |
1 | 200 | 9.600 |
1 | 2 | 9.540 |
1 | 330 | 9.510 |
2 | 1185 | 9.500 |
Price($) | Vol. | No. |
---|---|---|
9.910 | 475 | 2 |
9.990 | 99 | 1 |
10.000 | 250 | 1 |
10.500 | 10005 | 2 |
11.000 | 5000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online